FDA First-Cycle Approval Rate For NMEs Leaps To 50% In 2003
Executive Summary
FDA's effort to increase the rate that drug products are approved by their user fee goal date appears to be paying off, with significant improvement seen in 2003 compared to the year before
You may also be interested in...
First-Cycle Approval Rate Already High; Can PDUFA V Actually Boost It?
FDA official says the rate of approving applications in the first review cycle may not increase much more, even as the new review model, intended to promote more first-cycle approvals, has yet to finish with its inaugural applications.
Key To First-Cycle Approval Is To Meet Early And Often, Consultants Tell FDA
An independent analysis of FDA's first-cycle review performance provides support for the agency's request for additional funding for pre-submission meetings
Key To First-Cycle Approval Is To Meet Early And Often, Consultants Tell FDA
An independent analysis of FDA's first-cycle review performance provides support for the agency's request for additional funding for pre-submission meetings